ZNF582 and squamous cell carcinoma: ZNF582 promoter hypermethylation has been confirmed in multiple of studies of cervical precancerous lesions, and invasive adeno- and squamous carcinomas (Huang et al., 2012; Chang et al., 2014; Lai et al., 2014; Lin et al., 2014; Liang et al., 2020).